Barbosec
Barbosec Brand names, Barbosec Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Barbosec Brand Names Mixture
- No information avaliable
Barbosec Chemical_Formula
C12H18N2O3
Barbosec RX_link
No information avaliable
Barbosec fda sheet
Barbosec msds (material safety sheet)
Barbosec Synthesis Reference
No information avaliable
Barbosec Molecular Weight
238.283 g/mol
Barbosec Melting Point
100 oC
Barbosec H2O Solubility
550 mg/L
Barbosec State
Solid
Barbosec LogP
1.879
Barbosec Dosage Forms
Capsule
Barbosec Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Barbosec Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Barbosec Absorption
No information avaliable
Barbosec side effects and Toxicity
No information avaliable
Barbosec Patient Information
No information avaliable
Barbosec Organisms Affected
Humans and other mammals
